These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 31735133

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Idiopathic remitting seronegative symmetrical synovitis with pitting edema syndrome associated with bilateral pleural and pericardial effusions: a case report.
    Yanamoto S, Fukae J, Fukiyama Y, Fujioka S, Ouma S, Tsuboi Y.
    J Med Case Rep; 2016 Jul 20; 10():198. PubMed ID: 27439425
    [Abstract] [Full Text] [Related]

  • 11. Pazopanib- and bevacizumab-induced reversible heart failure in a patient with metastatic renal cell carcinoma: A case report.
    Abdallah AO, Vallurupalli S, Kunthur A.
    J Oncol Pharm Pract; 2016 Jun 20; 22(3):561-5. PubMed ID: 25956420
    [No Abstract] [Full Text] [Related]

  • 12. Remitting seronegative symmetrical synovitis with pitting edema syndrome induced by pembrolizumab in patient with urothelial carcinoma.
    Yoshimura A, Yamanaka K, Tadokoro R, Wakita T, Fukae S, Yoshida T, Sekiguchi M, Kishikawa H.
    IJU Case Rep; 2022 Jul 20; 5(4):219-222. PubMed ID: 35795121
    [Abstract] [Full Text] [Related]

  • 13. Synchronous Occurrence of Bazex Syndrome and Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome in a Patient with Lung Cancer.
    Aoshima Y, Karayama M, Sagisaka S, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T.
    Intern Med; 2019 Nov 15; 58(22):3267-3271. PubMed ID: 31292397
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome induced by nivolumab.
    Gauci ML, Baroudjian B, Laly P, Madelaine I, Da Meda L, Vercellino L, Bagot M, Lioté F, Pages C, Lebbé C.
    Semin Arthritis Rheum; 2017 Oct 15; 47(2):281-287. PubMed ID: 28438383
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Successful re-administration of Pazopanib in a patient with metastatic renal cell carcinoma and a history of Pazopanib-induced nephrotic syndrome: a case report.
    Jeon SY, Lee NR, Yim CY.
    BMC Nephrol; 2019 Jan 03; 20(1):1. PubMed ID: 30606155
    [Abstract] [Full Text] [Related]

  • 19. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE syndrome).
    Hung SC, Kung YY, Lin HY.
    J Formos Med Assoc; 1999 Jul 03; 98(7):516-8. PubMed ID: 10463003
    [Abstract] [Full Text] [Related]

  • 20. Pegilodecakin as monotherapy or in combination with anti-PD-1 or tyrosine kinase inhibitor in heavily pretreated patients with advanced renal cell carcinoma: Final results of cohorts A, G, H and I of IVY Phase I study.
    Tannir NM, Papadopoulos KP, Wong DJ, Aljumaily R, Hung A, Afable M, Kim JS, Ferry D, Drakaki A, Bendell J, Naing A.
    Int J Cancer; 2021 Jul 15; 149(2):403-408. PubMed ID: 33709428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.